Close Menu

First there were gene arrays, followed by protein arrays. Now, biotech firm Biolog is one step closer to commercializing the first living mammalian cell arrays for drug-discovery and -development applications.

The Hayward, Calif.-based company announced last week that it has received a $2.5 million Phase II SBIR grant from the National Institutes of Health to develop predictive toxicology assays for human and mouse cells on its Phenotype Microarray cellular array technology.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers trace DNA on a clay pipe found at a former slave site to a population that lives in what is now Sierra Leone, the Washington Post reports.

Japan is to release rules governing some gene-edited food, according to NHK World.

Two researchers report on their genetic analysis of samples from a shawl thought to belong to a victim of Jack the Ripper, ScienceInsider reports.

In PLOS this week: computational strategy for improving gene set analysis testing, miRNAs linked to sleep apnea, and more.